As of May 13, 2025, Cardio Diagnostics Holdings's market capitalization has reached $8.20 M. According to our data, Cardio Diagnostics Holdings is the 40276th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Cardio Diagnostics Holdings has seen its market value drop from $10.09 M to $8.20 M since 2022, representing a total decrease of 18.67% and an annual compound decline rate (CAGR) of 8.35%.
Date
Market Cap
Change (%)
May 13, 2025
$8.20 M
-73.97%
December 31, 2024
$37.08 M
-27.41%
December 29, 2023
$51.09 M
406.53%
December 30, 2022
$10.09 M
Company Profile
Cardio Diagnostics Holdings was founded in 2017 in United States.
on the Nasdaq Stock Market.
With 15 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
As of May 13, 2025, Cardio Diagnostics Holdings (including the parent company, if applicable) has an estimated market capitalization of $8.20 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Cardio Diagnostics Holdings global market capitalization ranking is approximately 40276 as of May 13, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.